SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001970051-23-000019
Filing Date
2023-11-01
Accepted
2023-11-01 09:26:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2785
  Complete submission text file 0001970051-23-000019.txt   4362
Mailing Address C/O SEELOS THERAPEUTICS, INC. 300 PARK AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address
O'Connor Daniel J. (Reporting) CIK: 0001376847 (see all company filings)

Type: 144

Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma, Inc. (Subject) CIK: 0001990550 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-56600 | Film No.: 231366801
SIC: 2836 Biological Products, (No Diagnostic Substances)